Cardiac Ablation Market - Top Companies and Manufacturers

  • Report ID: 4773
  • Published Date: Jul 31, 2024
  • Report Format: PDF, PPT

Companies Dominating the Cardiac Ablation Landscape

    • Medtronic
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • AngioDynamics
    • Atricure, Inc.
    • Alcon
    • Boston Scientific Corporation
    • Olympus Corporation
    • CONMED Corporation
    • Medical Device Business Services, Inc.
    • BIOTRONIK SE & Co KG
    • Biosense Webster, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Medtronic, announced the signing of a formal agreement to purchase Affera, Inc., a privately held medical technology business situated in the Boston region. For the treatment of patients with cardiac arrhythmias (irregular heartbeats) such atrial fibrillation, Affera develops and produces catheter-based cardiac ablation technologies, such as a unique localized pulsed field ablation solution (AF).

  •  Biosense Webster, Inc., a subsidiary of Johnson & Johnson MedTech, announced the availability of the OCTARAY Mapping Catheter with TRUEref Technology, which is driven by the CARTO 3 Version 7 System. Atrial fibrillation and other cardiac arrhythmias were produced using the OCTARAY Mapping Catheter (AFib).


Author Credits:  Radhika Pawar


  • Report ID: 4773
  • Published Date: Jul 31, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of cardiac ablation is assessed at USD 3.82 Billion.

The cardiac ablation market size was valued at USD 3.41 Billion in 2023 and is projected to reach USD 17.66 Billion by the end of 2036, expanding at around 13.5% CAGR during the forecast period i.e., between 2024-2036. The major factors driving the growth of the market are growing prevalence of diabetes mellitus, rising geriatric population, surge in investment in healthcare sector, and others.

North America is anticipated to hold largest industry share by 2036, backed by presence of key pharmaceutical equipment companies, along with rise in number of clinical trials.

Medtronic, AngioDynamics, Atricure, Inc., Alcon, Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Medical Device Business Services, Inc., BIOTRONIK SE & Co KG, Biosense Webster, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample